Education
About Us
Working with TipRanks
Follow Us
IEV - ETF AI Analysis
Top Page
iShares Europe ETF (IEV)
Rating:65Neutral
Price Target:―
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Geographic Diversification Across Major European Markets
Holdings spread across the UK, France, Germany, Switzerland, and other European countries help reduce reliance on any single market.
Exposure to Strong Individual Winners
Top holding ASML and several other large positions have delivered strong year-to-date performance, supporting the fund’s overall returns.
Negative Factors
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an index ETF, which can gradually eat into long-term returns.
Mixed Performance Among Top Holdings
Some major positions like AstraZeneca, Nestlé, SAP, and Shell have shown weak or negative year-to-date performance, which can drag on the ETF’s results.
Heavy Tilt Toward Financials and Industrials
A large share of assets in financial and industrial stocks increases the fund’s sensitivity to economic cycles and sector-specific downturns.
IEV vs. SPDR S&P 500 ETF (SPY)
AUM1.64B
RegionEurope
Expense Ratio0.60%
Beta0.69
IssueriShares
Inception DateJul 25, 2000
Dividend Yield2.78%
Asset ClassEquity
Index TrackedS&P Europe 350
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume387,899
30 Day Avg. Volume276,887
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
77.47Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering358
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IEV Summary
The iShares Europe ETF (IEV) is a fund that follows the S&P Europe 350 Index, which includes 350 of the largest companies across developed European countries like the UK, France, Germany, and Switzerland. It owns many well-known names such as Nestlé and AstraZeneca, spread across sectors like finance, industrials, health care, and technology. Someone might invest in IEV to get broad international diversification and long-term growth potential from leading European businesses in a single investment. A key risk is that the value can rise and fall with the European stock market and currency movements.
How much will it cost me?The iShares Europe ETF (IEV) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is slightly higher than average for ETFs because it tracks a broad index of European large-cap stocks, which requires more management compared to passively managed U.S. index funds.
What would affect this ETF?The iShares Europe ETF (IEV) could benefit from economic recovery and growth in developed European markets, especially if sectors like financials and industrials, which make up a significant portion of its holdings, perform well. However, challenges such as rising interest rates, geopolitical tensions, or regulatory changes in Europe could negatively impact its performance, particularly for top holdings in industries like healthcare and technology that are sensitive to such factors.
IEV Top 10 Holdings
IEV is leaning heavily on Europe’s health-care heavyweights, with Roche, AstraZeneca, and Novartis all rising and quietly doing the heavy lifting for the fund. ASML has been a standout growth engine, adding tech sparkle despite its relatively small weight. Big banks like HSBC and Banco Santander are also climbing, giving a helpful boost from the financial side. On the flip side, SAP and, to a lesser extent, Siemens have been lagging, acting as a bit of a brake. Overall, it’s a diversified, developed-Europe story with no single stock dominating the show.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 4.00% | $65.23M | €450.89B | 82.31% | 76 Outperform | |
| AstraZeneca | 2.26% | $36.80M | $297.58B | 20.89% | 80 Outperform | |
| Novartis AG | 2.23% | $36.27M | CHF229.98B | 24.67% | 80 Outperform | |
| Roche Holding AG | 2.17% | $35.36M | CHF254.35B | 25.81% | 73 Outperform | |
| HSBC Holdings | 2.08% | $33.93M | £205.38B | 40.17% | 80 Outperform | |
| Nestlé SA | 2.00% | $32.53M | CHF202.39B | 2.00% | 71 Outperform | |
| Shell (UK) | 1.94% | $31.66M | £187.41B | 27.85% | 73 Outperform | |
| SAP SE | 1.48% | $24.17M | €190.17B | -30.37% | 66 Neutral | |
| Siemens | 1.45% | $23.59M | €171.28B | -1.14% | 74 Outperform | |
| Banco Santander | 1.25% | $20.44M | €141.56B | 62.92% | 73 Outperform |
IEV Technical Analysis
Negative
―
Price Trends
71.34
Negative
68.84
Negative
66.00
Positive
Market Momentum
-0.98
Positive
29.25
Positive
19.10
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IEV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 71.58, equal to the 50-day MA of 71.34, and equal to the 200-day MA of 66.00, indicating a neutral trend. The MACD of -0.98 indicates Positive momentum. The RSI at 29.25 is Positive, neither overbought nor oversold. The STOCH value of 19.10 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IEV.
IEV Peer Comparison
Comparison Results
Performance Comparison
IEV
iShares Europe ETF
67.39
8.69
14.80%
EZU
iShares MSCI Eurozone ETF
―
―
―
BBEU
JPMorgan BetaBuilders Europe ETF
―
―
―
IEUR
iShares Core MSCI Europe ETF
―
―
―
FEZ
SPDR EURO STOXX 50 ETF
―
―
―
HEDJ
WisdomTree Europe Hedged Equity Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents